{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:38:02Z","timestamp":1787618282956,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sichuan Province Natural Science Foundation","award":["2024NSFSC1937"],"award-info":[{"award-number":["2024NSFSC1937"]}]},{"name":"Sichuan Province Natural Science Foundation","award":["2023NSFSC0664"],"award-info":[{"award-number":["2023NSFSC0664"]}]},{"name":"Sichuan Province Natural Science Foundation","award":["2024NSFSC1695"],"award-info":[{"award-number":["2024NSFSC1695"]}]},{"name":"1\u00b73\u00b75 Project for Disciplines of Excellence in Artificial Intelligence","award":["ZYAI24024"],"award-info":[{"award-number":["ZYAI24024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-04648-8","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T07:36:02Z","timestamp":1769067362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparative effectiveness of sleeve gastrectomy and semaglutide for weight loss and metabolic outcomes: a prospective non-randomized study"],"prefix":"10.1186","volume":"24","author":[{"given":"Yutung","family":"Yen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohai","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoding","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyi","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0103-6147","authenticated-orcid":false,"given":"Jason","family":"Widjaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4885-6097","authenticated-orcid":false,"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"issue":"7","key":"4648_CR1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/obr.12551","volume":"18","author":"GA Bray","year":"2017","unstructured":"Bray GA, Kim KK, Wilding JPH, World Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017;18(7):715\u201323.","journal-title":"Obes Rev"},{"issue":"2","key":"4648_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.gtc.2023.03.002","volume":"52","author":"N Alfaris","year":"2023","unstructured":"Alfaris N, Alqahtani AM, Alamuddin N, Rigas G. Global impact of obesity. Gastroenterol Clin North Am. 2023;52(2):277\u201393.","journal-title":"Gastroenterol Clin North Am"},{"issue":"21","key":"4648_CR3","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","volume":"143","author":"TM Powell-Wiley","year":"2021","unstructured":"Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;143(21):e984\u20131010.","journal-title":"Circulation"},{"issue":"5","key":"4648_CR4","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1007\/s11695-024-07196-3","volume":"34","author":"WA Brown","year":"2024","unstructured":"Brown WA, Liem R, Al-Sabah S, et al. Metabolic bariatric surgery across the IFSO chapters: key insights on the baseline patient demographics, procedure types, and mortality from the eighth IFSO global registry report. Obes Surg. 2024;34(5):1764\u201377.","journal-title":"Obes Surg"},{"issue":"10390","key":"4648_CR5","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/S0140-6736(23)00634-7","volume":"401","author":"O Verrastro","year":"2023","unstructured":"Verrastro O, Panunzi S, Castagneto-Gissey L, et al. Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial. Lancet. 2023;401(10390):1786\u201397.","journal-title":"Lancet"},{"issue":"4","key":"4648_CR6","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2337\/dc24-2046","volume":"48","author":"DC Simonson","year":"2025","unstructured":"Simonson DC, Gourash WF, Arterburn DE, et al. Health-related quality of life and health utility after metabolic\/bariatric surgery versus medical\/lifestyle intervention in individuals with type 2 diabetes and obesity: the ARMMS-T2D study. Diabetes Care. 2025;48(4):537\u201345.","journal-title":"Diabetes Care"},{"key":"4648_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155655","volume":"147","author":"AC Koschker","year":"2023","unstructured":"Koschker AC, Warrings B, Morbach C, et al. Effect of bariatric surgery on cardio-psycho-metabolic outcomes in severe obesity: a randomized controlled trial. Metabolism. 2023;147:155655.","journal-title":"Metabolism"},{"issue":"4","key":"4648_CR8","doi-asserted-by":"publisher","first-page":"O1","DOI":"10.1002\/oby.22719","volume":"28","author":"JI Mechanick","year":"2020","unstructured":"Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists\/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Obesity (Silver Spring). 2020;28(4):O1\u201358.","journal-title":"Obesity (Silver Spring)"},{"issue":"11","key":"4648_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13087","volume":"21","author":"M O'Kane","year":"2020","unstructured":"O\u2019Kane M, Parretti HM, Pinkney J, et al. British Obesity and Metabolic Surgery Society guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery-2020 update. Obes Rev. 2020;21(11):e13087.","journal-title":"Obes Rev"},{"issue":"7","key":"4648_CR10","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/jama.2024.10816","volume":"332","author":"KA Gudzune","year":"2024","unstructured":"Gudzune KA, Kushner RF. Medications for obesity: a review. JAMA. 2024;332(7):571\u201384.","journal-title":"JAMA"},{"issue":"1","key":"4648_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/dom.14863","volume":"25","author":"NC Bergmann","year":"2023","unstructured":"Bergmann NC, Davies MJ, Lingvay I, Knop FK. Semaglutide for the treatment of overweight and obesity: a review. Diabetes Obes Metab. 2023;25(1):18\u201335.","journal-title":"Diabetes Obes Metab"},{"issue":"10278","key":"4648_CR12","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","volume":"397","author":"M Davies","year":"2021","unstructured":"Davies M, F\u00e6rch L, Jeppesen OK, et al. Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021;397(10278):971\u201384.","journal-title":"Lancet"},{"issue":"6","key":"4648_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa2107519","volume":"385","author":"JP Fr\u00edas","year":"2021","unstructured":"Fr\u00edas JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N Engl J Med. 2021;385(6):503\u201315.","journal-title":"N Engl J Med"},{"issue":"2","key":"4648_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1001\/jama.2021.23619","volume":"327","author":"DM Rubino","year":"2022","unstructured":"Rubino DM, Greenway FL, Khalid U, et al. Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial. JAMA. 2022;327(2):138\u201350.","journal-title":"JAMA"},{"key":"4648_CR15","doi-asserted-by":"crossref","unstructured":"Chen CM. Overview of obesity in Mainland China. Obes Rev. 2008;9 (Suppl) 1:14\u201321.","DOI":"10.1111\/j.1467-789X.2007.00433.x"},{"issue":"3","key":"4648_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S2213-8587(22)00008-0","volume":"10","author":"T Kadowaki","year":"2022","unstructured":"Kadowaki T, Isendahl J, Khalid U, et al. Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an East Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial. Lancet Diabetes Endocrinol. 2022;10(3):193\u2013206.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"4648_CR17","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/jdi.14186","volume":"15","author":"N Sukkriang","year":"2024","unstructured":"Sukkriang N, Buranapin S. Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: a randomized controlled trial. J Diabetes Investig. 2024;15(9):1297\u2013305.","journal-title":"J Diabetes Investig"},{"key":"4648_CR18","doi-asserted-by":"publisher","DOI":"10.2196\/45461","volume":"8","author":"Y Le Mat","year":"2024","unstructured":"Le Mat Y, Casali C, Le Mat F, et al. Impact of a self-autonomous evaluation station and personalized training algorithm on quality of life and physical capacities in sedentary adults: randomized controlled trial. JMIR Form Res. 2024;8:e45461.","journal-title":"JMIR Form Res"},{"issue":"9","key":"4648_CR19","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/j.1742-1241.2012.02992.x","volume":"66","author":"J Ponce","year":"2012","unstructured":"Ponce J, Garrigues V, Agr\u00e9us L, et al. Structured management strategy based on the Gastro-oesophageal Reflux Disease (GERD) questionnaire (GerdQ) vs. usual primary care for GERD: pooled analysis of five cluster-randomised European studies. Int J Clin Pract. 2012;66(9):897\u2013905.","journal-title":"Int J Clin Pract"},{"issue":"1","key":"4648_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11695-018-3525-0","volume":"29","author":"PE O'Brien","year":"2019","unstructured":"O\u2019Brien PE, Hindle A, Brennan L, et al. Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding. Obes Surg. 2019;29(1):3\u201314.","journal-title":"Obes Surg"},{"issue":"8","key":"4648_CR21","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1001\/jamasurg.2022.2229","volume":"157","author":"P Salminen","year":"2022","unstructured":"Salminen P, Gr\u00f6nroos S, Helmi\u00f6 M, et al. Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: the SLEEVEPASS Randomized Clinical Trial. JAMA Surg. 2022;157(8):656\u201366.","journal-title":"JAMA Surg"},{"issue":"4","key":"4648_CR22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/jamasurg.2024.7052","volume":"160","author":"M Kraljevic","year":"2025","unstructured":"Kraljevic M, S\u00fcsstrunk J, W\u00f6lnerhanssen BK, et al. Long-term outcomes of laparoscopic Roux-en-Y gastric bypass vs laparoscopic sleeve gastrectomy for obesity: the SM-BOSS randomized clinical trial. JAMA Surg. 2025;160(4):369\u201377.","journal-title":"JAMA Surg"},{"issue":"8","key":"4648_CR23","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/dom.14725","volume":"24","author":"JPH Wilding","year":"2022","unstructured":"Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553\u201364.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"4648_CR24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.57349","volume":"8","author":"PJ Rodriguez","year":"2025","unstructured":"Rodriguez PJ, Zhang V, Gratzl S, et al. Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among US adults with overweight or obesity. JAMA Netw Open. 2025;8(1):e2457349.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"4648_CR25","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1111\/dom.16353","volume":"27","author":"JY Wu","year":"2025","unstructured":"Wu JY, Chan SE, Hsu WH, et al. Comparing clinical outcomes of adults with obesity receiving tirzepatide versus bariatric metabolic surgery: a multi-institutional propensity score-matched study. Diabetes Obes Metab. 2025;27(6):3357\u201366.","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"4648_CR26","volume":"15","author":"N Klair","year":"2023","unstructured":"Klair N, Patel U, Saxena A, et al. What is best for weight loss? A comparative review of the safety and efficacy of bariatric surgery versus glucagon-like peptide-1 analogue. Cureus. 2023;15(9):e46197.","journal-title":"Cureus"},{"issue":"11","key":"4648_CR27","doi-asserted-by":"publisher","first-page":"6560","DOI":"10.1007\/s00464-024-11191-1","volume":"38","author":"S Docimo Jr","year":"2024","unstructured":"Docimo S Jr, Shah J, Warren G, Ganam S, Sujka J, DuCoin C. A cost comparison of GLP-1 receptor agonists and bariatric surgery: what is the break even point? Surg Endosc. 2024;38(11):6560\u20135.","journal-title":"Surg Endosc"},{"issue":"5","key":"4648_CR28","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jamasurg.2025.0001","volume":"160","author":"V Mathur","year":"2025","unstructured":"Mathur V, Wasden K, Shin TH, et al. Neoadjuvant semaglutide, bariatric surgery weight loss, and overall outcomes. JAMA Surg. 2025;160(5):594\u20136.","journal-title":"JAMA Surg"},{"issue":"1","key":"4648_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-025-01913-4","volume":"25","author":"AB Jensen","year":"2025","unstructured":"Jensen AB, Machado U, Renstr\u00f6m F, et al. Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on weight regain after bariatric surgery: a real-world retrospective observational study. BMC Endocr Disord. 2025;25(1):93.","journal-title":"BMC Endocr Disord"},{"issue":"10","key":"4648_CR30","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1007\/s11695-022-06211-9","volume":"32","author":"A Lautenbach","year":"2022","unstructured":"Lautenbach A, Wernecke M, Huber TB, et al. The potential of semaglutide once-weekly in patients without type 2 diabetes with weight regain or insufficient weight loss after bariatric surgery-a retrospective analysis. Obes Surg. 2022;32(10):3280\u20138.","journal-title":"Obes Surg"},{"issue":"7","key":"4648_CR31","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1007\/s11695-021-05415-9","volume":"31","author":"P Noparatayaporn","year":"2021","unstructured":"Noparatayaporn P, Thavorncharoensap M, Chaikledkaew U, Bagepally BS, Thakkinstian A. Incremental net monetary benefit of bariatric surgery: systematic review and meta-analysis of cost-effectiveness evidences. Obes Surg. 2021;31(7):3279\u201390.","journal-title":"Obes Surg"},{"issue":"6","key":"4648_CR32","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1001\/jamasurg.2025.0490","volume":"160","author":"S Bansal","year":"2025","unstructured":"Bansal S, Bader A, Mahmud N, Kaplan DE. Survival and cost-effectiveness of bariatric surgery among patients with obesity and cirrhosis. JAMA Surg. 2025;160(6):645\u201355.","journal-title":"JAMA Surg"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04648-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04648-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04648-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T02:02:40Z","timestamp":1771293760000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04648-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4648"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04648-8","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of our institution (approval number 2023.133). This study was registered at the Chinese Clinical Trial Registry (ChiCTR2300070632) (\n                      \n                      ). Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}